GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...

OH, a kratom derivative, is marketed as a natural remedy, but the FDA says it’s dangerous. About the hidden risks and what ...

The Food and Drug Administration announced on Thursday significant labeling changes that will affect all opioid pain ...

FuturHealth, a leading provider of personalized weight-loss solutions, today announced it is giving its members seamless ...

Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.

Alzheimer’s disease remains one of medicine’s toughest challenges, affecting millions and costing trillions of dollars ...

Researchers from Southern Medical University and collaborators report the identification of FDA‑approved compounds that may ...

Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Revalesio, a clinical-stage biopharmaceutical company developing treatments for acute and chronic neurological disorders, today announced that the U.S. Food and Drug Administration has granted Fast ...

Speakers at a congressional briefing on July 22 called on the FDA to take action against the marketing and distribution of ...

The FDA has approved a new treatment, sold under the name Anzupgo and containing a drug called delgocitinib, as the first ...

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.